CNBCPfizer will combine its off-patent drug business with MylanJul 29, 2019Meg TirrellBy Meg Tirrellbookmark_bordersharemore_vert
FiercePharmaMylan CEO Bresch set to exit after years of controversy—and one last big dealJul 29, 2019Eric SagonowskyBy Eric Sagonowskybookmark_bordersharemore_vert
CBS NewsPfizer Mylan merger: Pfizer to combine drug units in new generic businessJul 29, 2019bookmark_bordersharemore_vert
The New York TimesPfizer to Merge Its Off-Patent Drug Unit With Mylan (Published 2019)Jul 29, 2019Katie Thomas & Michael de la MercedBy Katie Thomas & Michael de la Mercedbookmark_bordersharemore_vert